391 related articles for article (PubMed ID: 25867219)
21. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
[TBL] [Abstract][Full Text] [Related]
22. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway.
Sano T; Izuishi K; Hossain MA; Inoue T; Kakinoki K; Hagiike M; Okano K; Masaki T; Suzuki Y
Transplantation; 2011 May; 91(10):1082-9. PubMed ID: 21403587
[TBL] [Abstract][Full Text] [Related]
23. Toll-Like Receptor 4 (TLR4) expression and stimulation in a model of intervertebral disc inflammation and degeneration.
Rajan NE; Bloom O; Maidhof R; Stetson N; Sherry B; Levine M; Chahine NO
Spine (Phila Pa 1976); 2013 Jul; 38(16):1343-51. PubMed ID: 22850250
[TBL] [Abstract][Full Text] [Related]
24. [Effects of vasoactive intestinal peptide on Toll-like receptor (TLR) 2 mRNA and TLR4 mRNA expression on acute lung injury induced by lipopolysaccharide in rat].
Zuo WQ; Zhang YC; Gong XH; Zhang YM
Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):19-23. PubMed ID: 20441697
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
26. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators.
Lehner MD; Morath S; Michelsen KS; Schumann RR; Hartung T
J Immunol; 2001 Apr; 166(8):5161-7. PubMed ID: 11290799
[TBL] [Abstract][Full Text] [Related]
27. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of endotoxin and lipoteichoic acid virulence using toll receptor reporter gene.
Huggins T; Haught JC; Xie S; Tansky CS; Klukowska M; Miner MC; White DJ
Am J Dent; 2016 Dec; 29(6):321-327. PubMed ID: 29178719
[TBL] [Abstract][Full Text] [Related]
29. Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.
van Aubel RA; Keestra AM; Krooshoop DJ; van Eden W; van Putten JP
Mol Immunol; 2007 Jul; 44(15):3702-14. PubMed ID: 17493681
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of macrophage stimulation by lipoteichoic acid and the costimulant hemoglobin is dependent on Toll-like receptors 2 and 4.
Cox KH; Ofek I; Hasty DL
Infect Immun; 2007 May; 75(5):2638-41. PubMed ID: 17296755
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte adhesion molecule and chemokine production through lipoteichoic acid recognition by toll-like receptor 2 in cultured human lymphatic endothelium.
Sawa Y; Tsuruga E; Iwasawa K; Ishikawa H; Yoshida S
Cell Tissue Res; 2008 Aug; 333(2):237-52. PubMed ID: 18523807
[TBL] [Abstract][Full Text] [Related]
32. Different potency of bacterial antigens TLR2 and TLR4 ligands in stimulating mature mast cells to cysteinyl leukotriene synthesis.
Bąbolewska E; Witczak P; Pietrzak A; Brzezińska-Błaszczyk E
Microbiol Immunol; 2012 Mar; 56(3):183-90. PubMed ID: 22233438
[TBL] [Abstract][Full Text] [Related]
33. Hyperthermia differentially regulates TLR4 and TLR2-mediated innate immune response.
Zhao W; An H; Zhou J; Xu H; Yu Y; Cao X
Immunol Lett; 2007 Feb; 108(2):137-42. PubMed ID: 17196259
[TBL] [Abstract][Full Text] [Related]
34. Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responses.
Dammermann W; Wollenberg L; Bentzien F; Lohse A; Lüth S
J Immunol Methods; 2013 Oct; 396(1-2):107-15. PubMed ID: 23954282
[TBL] [Abstract][Full Text] [Related]
35. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
Aletaha S; Haddad L; Roozbehkia M; Bigdeli R; Asgary V; Mahmoudi M; Mirshafiey A
Scand J Immunol; 2017 Feb; 85(2):122-129. PubMed ID: 27943385
[TBL] [Abstract][Full Text] [Related]
36. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways.
Yokoyama T; Komori A; Nakamura M; Takii Y; Kamihira T; Shimoda S; Mori T; Fujiwara S; Koyabu M; Taniguchi K; Fujioka H; Migita K; Yatsuhashi H; Ishibashi H
Liver Int; 2006 May; 26(4):467-76. PubMed ID: 16629651
[TBL] [Abstract][Full Text] [Related]
37. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes.
Matsumura T; Ito A; Takii T; Hayashi H; Onozaki K
J Interferon Cytokine Res; 2000 Oct; 20(10):915-21. PubMed ID: 11054280
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of Toll-like receptor 2 and 4 on macrophages in experimental severe acute pancreatitis.
Matsumura N; Takeyama Y; Ueda T; Yasuda T; Shinzeki M; Sawa H; Nakajima T; Kuroda Y
Kobe J Med Sci; 2007; 53(5):219-27. PubMed ID: 18204298
[TBL] [Abstract][Full Text] [Related]
39. TAK1 contributes to the enhanced responsiveness of LTB(4)-treated neutrophils to Toll-like receptor ligands.
Gaudreault É; Paquet-Bouchard C; Fiola S; Le Bel M; Lacerte P; Shio MT; Olivier M; Gosselin J
Int Immunol; 2012 Nov; 24(11):693-704. PubMed ID: 22843747
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
